Boston

Appeals court upholds FTC view of controversial pay-to-delay settlements – Boston, Massachusetts

Boston, Massachusetts 2021-04-13 15:56:44 –

In What is called a victory for consumers, the US Court of Appeals support The Federal Trade Commission’s decision that so-called late payment transactions between two pharmaceutical companies are anti-competitive.

The problem was Endo International in 2010 (ENDP) And Impax Laboratories have agreed not to sell a generic version of Endo’s OpanaER painkillers for three years in exchange for $ 112 million. At that time, opioids generated $ 172 million in sales, or about 12% of Endo’s total revenue. The FTC claims that the deal means Endo will not face low-cost competition until at least January 2013, resulting in consumers and other buyers paying “more than hundreds of millions of dollars a year” for drugs. did.

Sign up for STAT + to unlock this article and enjoy the first 30 days for free!

let’s start



Appeals court upholds FTC view of controversial pay-to-delay settlements Source link Appeals court upholds FTC view of controversial pay-to-delay settlements

Back to top button